Abstract
IntroductionAntiretroviral therapy (ART) has reduced HIV morbidity and mortality worldwide but has many adverse effects. These adverse drug reactions (ADRs) lead to discontinuations, disease progression or treatment failure. We explored the types and risk factors for ADRs in a cohort starting ART in a teaching hospital in Accra, Ghana where the main regimens used were a combination of nucleotide and non nucleotide reverse transcriptase inhibitors.MethodsA Cross-sectional retrospective study was conducted reviewing data of 2042 patients initiated on HAART from 2003 to 2007. Univariate analysis was done for the dependent and independent variables. Stepwise logistic regression procedures were used to model the effect of gender on the development of ADRs controlling for other variables like age, marital status, weight at baseline and CD4 at baseline.ResultsThe period prevalence of ADRs was 9.4%. The two most common adverse reactions were anaemia and diarrhoea. Female sex was a statistically significant independent predictor of an adverse drug reaction (AOR: 1.66, p = 0.01, CI: 1.16-2.36). CD4 counts 250 cells/mm3 or more was significantly associated with the occurrence of an ADR. The occurrence of anaemia in females was statistically significant compared to males.ConclusionAdverse drug reactions were less common than expected, anaemia was the commonest ADR. Female sex and high CD4 counts >250mm3 were predictors of ADRs whereas females were significantly more likely to develop anaemia than males. Recommendations were made for interventions to prevent and also mitigate the high levels of anaemia especially among women in the ART scale up.
Highlights
Antiretroviral therapy (ART) has reduced HIV morbidity and mortality worldwide but has many adverse effects
highly active antiretroviral therapy (HAART) may be modified or interrupted as a result of many reasons, key among which are adverse effects and virological failure [4,5,6,7].The adverse effects may in themselves result in virological failure or disease progression as a result of sub optimal dosing or treatment interruption
The study population included all patients attending the Fevers Unit between December 2003 and June 2007 and who were naïve to antiretroviral therapy before the initiation of HAART and with valid data in database
Summary
Antiretroviral therapy (ART) has reduced HIV morbidity and mortality worldwide but has many adverse effects. These adverse drug reactions (ADRs) lead to discontinuations, disease progression or treatment failure. Female sex was a statistically significant independent predictor of an adverse drug reaction (AOR: 1.66, p=0.01, CI: 1.16-2.36). Female sex and high CD4 counts >250mm were predictors of ADRs whereas females were significantly more likely to develop anaemia than males. In a study done in India, 90.6% of all the patients on HAART developed an adverse drug reaction and there were 618 episodes in various systems, the abdominal and central nervous systems were the most affected [8]. Anaemia was observed as an ADR in cohorts on ART, whether or not they took zidovudine (ZDV) [10]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have